Pneumoconiosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(5 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
{{Pneumoconiosis}} | {{Pneumoconiosis}} | ||
{{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]] | {{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]] | ||
==Overview== | |||
Effective measures for the secondary prevention of [[pneumoconiosis]] include avoiding further [[Exposure and response prevention|exposure]] and being [[vaccinated]]. <ref name="pmid23708110">{{cite journal| author=Cullinan P, Reid P| title=Pneumoconiosis. | journal=Prim Care Respir J | year= 2013 | volume= 22 | issue= 2 | pages= 249-52 | pmid=23708110 | doi=10.4104/pcrj.2013.00055 | pmc=6442808 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23708110 }} </ref> | |||
==Secondary Prevention== | |||
Effective measures for the [[secondary prevention]] of [[pneumoconiosis]] include: <ref name="pmid21460389">{{cite journal| author=Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Cragle DL | display-authors=etal| title=Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. | journal=Occup Environ Med | year= 2011 | volume= 68 | issue= 11 | pages= 842-8 | pmid=21460389 | doi=10.1136/oem.2010.064220 | pmc=4347849 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21460389 }} </ref> <ref name="pmid19894178">{{cite journal| author=Sood A| title=Current treatment of chronic beryllium disease. | journal=J Occup Environ Hyg | year= 2009 | volume= 6 | issue= 12 | pages= 762-5 | pmid=19894178 | doi=10.1080/15459620903158698 | pmc=2774897 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19894178 }} </ref> <ref name="pmid9303953">{{cite journal| author=| title=IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Silica, Some Silicates, Coal Dust and Para-Aramid Fibrils. Lyon, 15-22 October 1996. | journal=IARC Monogr Eval Carcinog Risks Hum | year= 1997 | volume= 68 | issue= | pages= 1-475 | pmid=9303953 | doi= | pmc=5366849 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9303953 }} </ref> <ref name="pmid16403810">{{cite journal| author=Pelucchi C, Pira E, Piolatto G, Coggiola M, Carta P, La Vecchia C| title=Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996-2005. | journal=Ann Oncol | year= 2006 | volume= 17 | issue= 7 | pages= 1039-50 | pmid=16403810 | doi=10.1093/annonc/mdj125 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16403810 }} </ref> | |||
*Avoiding further [[Exposure and response prevention|exposure]] | |||
*[[Vaccination]] for [[influenza]] | |||
*[[Vaccination]] for [[pneumococcus]] | |||
*Health surveillance for workers | |||
*Stop [[smoking]] | |||
*Treat [[respiratory infections]] quickly | |||
==References== | ==References== |
Latest revision as of 20:26, 28 April 2021
Pneumoconiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumoconiosis secondary prevention On the Web |
American Roentgen Ray Society Images of Pneumoconiosis secondary prevention |
Risk calculators and risk factors for Pneumoconiosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
Effective measures for the secondary prevention of pneumoconiosis include avoiding further exposure and being vaccinated. [1]
Secondary Prevention
Effective measures for the secondary prevention of pneumoconiosis include: [2] [3] [4] [5]
- Avoiding further exposure
- Vaccination for influenza
- Vaccination for pneumococcus
- Health surveillance for workers
- Stop smoking
- Treat respiratory infections quickly
References
- ↑ Cullinan P, Reid P (2013). "Pneumoconiosis". Prim Care Respir J. 22 (2): 249–52. doi:10.4104/pcrj.2013.00055. PMC 6442808. PMID 23708110.
- ↑ Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Cragle DL; et al. (2011). "Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry". Occup Environ Med. 68 (11): 842–8. doi:10.1136/oem.2010.064220. PMC 4347849. PMID 21460389.
- ↑ Sood A (2009). "Current treatment of chronic beryllium disease". J Occup Environ Hyg. 6 (12): 762–5. doi:10.1080/15459620903158698. PMC 2774897. PMID 19894178.
- ↑ "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Silica, Some Silicates, Coal Dust and Para-Aramid Fibrils. Lyon, 15-22 October 1996". IARC Monogr Eval Carcinog Risks Hum. 68: 1–475. 1997. PMC 5366849. PMID 9303953.
- ↑ Pelucchi C, Pira E, Piolatto G, Coggiola M, Carta P, La Vecchia C (2006). "Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996-2005". Ann Oncol. 17 (7): 1039–50. doi:10.1093/annonc/mdj125. PMID 16403810.